bioRxivBioengineeringPreprint
Risk-Aware Control for Insulin Delivery via Nonlinear MPC with Safety Barrier Functions and Probabilistic Learning of Uncertainties
Aliasghar ArabiD, Seyedreza Mohamadi, Farid AlisafaeiiD, Yashar MousaviiD, Katsuo KurabayashiiD
Abstract
Maintaining blood glucose within a physiologically safe range is critical for people with diabetes, as deviations can lead to acute or chronic complications. Hypoglycemia, in particular, represents an immediate threat and requires prioritized mitigation in autonomous insulin delivery systems. This paper introduces a risk-aware hybrid nonlinear model predictive control (NMPC) framework that combines data-driven uncertainty quantification with formal safety assurance through control barrier functions (CBFs). To account for key uncertainties, such as physiological time delays, unannounced meals, and stress-induced glucose variability, Gaussian processes (GPs) are employed as probabilistic estimators. The proposed method dynamically monitors glucose and regulates insulin injection to enforce safe glucose level control by preventing hypoglycemia. The proposed framework is evaluated using validated physiological simulators for various realistic scenarios. The results show a robust performance in maintaining safety under high uncertainty, preparing a foundation for translation into next phase of our research as safe autonomous diabetes management systems.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Title: Zero-shot automated insulin delivery for type 1 diabetes via dynamic physiology-aware reinforcement learning
Junyoung Yoo, Vega Pradana Rachim, … Seong-Jin Park·bioRxiv·May 28, 2026
- Optimizing Glycemic Control in Type 1 Diabetic Patients using a Deep Learning-Based Artificial Pancreas with a Secure Glucagon and Insulin Delivery System
- Predictability failure in glucose-insulin system for ICU patients
Deepjyoti Ghosh·bioRxiv·Sep 1, 2026
- Ultra-stable insulin-glucagon fusion protein exploits an endogenous hepatic switch to mitigate hypoglycemic risk
Nicolás Varas, Mark A. Jarosinski, … Michael Aaron Weiss·ACS Pharmacology & Translational SciencePeer-reviewed·Aug 14, 2025
- Decoding Diabetes: Harnessing AI to Accurately Predict Real-Time and Future Blood Glucose Levels for Diabetes Management Using Diet, Exercise, Insulin Intake, and Heart Rate Variability
Riddhi Pritam Singhvi, Sanjay Singhvi·bioRxiv·Nov 2, 2025
- Patient-specific deep offline artificial pancreas for blood glucose regulation in type 1 diabetes
Yixiang Deng, Kevin Arao, … George Em Karniadakis·Smart HealthPeer-reviewed·Jan 18, 2026